Journal Guide

The journal publishes timely, critical reviews of topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Reviews are mainly solicited by the editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

The powerful emergence and global spread of antibiotic resistant microbial pathogens and resistance genes in the 1990s presents challenges to a wide range of disciplines - from the molecular biology of resistance mechanisms, virulence genes, and disease through molecular epidemiology all the way to drug design, infection control, and medical practice. This international journal provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Insights into the latest molecular diagnostic and pharmacogenomic techniques and their use in personalized medicine.

Molecular Diversity presents refereed papers describing the development, application and theory of molecular diversity, and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full-length papers, perspectives, news and reviews. Coverage addresses the generation of molecular diversity, application of diversity for screening against alternative targets of all types, analysis of results and their application in various scientific disciplines. Topics include combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display librar

Aims and Scope Download Flyer Molecular Informaticsis a peer-reviewed. international forum for publication of high-quality. interdisciplinary research on all molecular aspects of bio/cheminformatics and computer-assisted molecular design.Molecular InformaticssucceededQSAR and Combinatorial Science(2009 Journal Impact Factor: 3.027) in 2010. Molecular Informaticspresents methodological innovations that will lead to a deeper understanding of ligand-receptor interactions. macromolecular complexes. molecular networks. design concepts and processes that demonstrate how ideas and design concepts lead to molecules with a desired structure or function. preferably including experimental validation. The journal"s scope includes but is not limited to the fields of drug discovery and chemical biology. protein and nucleic acid engineering and design. the design of nanomolecular structures. strategies for modeling of macromolecular assemblies. molecular networks and systems. pharmaco- and chemogenomics. computer-assisted screening strategies. as well as novel technologies for the de novo design of biologically active molecules. As a unique featureMolecular Informaticspublishes so-called 'Methods Corner' review-type articles which feature important technological concepts and advances within the scope of the journal. ISSN: 1868-1743 (print). 1868-1751 (online). Volume 30. 12 Issues in 2011. Masthead Masthead(PDF) –[Show history][Hide history] How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'Mol. Inf.' (punctuation may vary according to the style of the citing journal).

Molecular Pharmaceutics publishes original theoretical and experimental research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:

• Modelling and simulation to aid mechanistic insights into drug delivery
• Molecular understanding of formulations
• Formulation performance under physiological conditions
• Materials science as it relates to drug, excipients, and drug delivery system efficacy.
• Emerging techniques and technologies for drug delivery including theranostics, precision medicine, and artificial intelligence

Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.

Monthly issues present original applications of biochemistry, biophysics, genetics, and molecular biology juxtaposed with innovative pharmacologic research to elucidate basic problems in pharmacology and toxicology, including areas such as molecular mechanisms involved in drug receptor-effective coupling, xenobiotic metabolism, and antibiotic and anticancer drug action.Molecular Pharmacology is archived in CLOCKSS.

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Available in print and online, Molecular Therapy is dedicated to promoting the sciences in genetics, medicine and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2009 impact factor is 6.239*.

Molecular Therapy — Nucleic Acids publishes research targeted to the advances in nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, and applications of gene-modifying agents.

Molecular & Cellular Toxicology (MCT) is owned and published by the Korean Society of Toxicogenomics and Toxicoproteomics. It is published four times a year in a printed version. Its editorial policies are the responsibility of the editor, the associated editors, and the editorial board under the general authority of the publications committee and the council.

Our aim is to encourage chemists to publish as much as possible their experimental detail, particularly synthetic procedures and characterization information. There is no restriction on the length of the experimental section. In addition, availability of compound samples is published and considered as important information. Authors are encouraged to register or deposit their chemical samples through the non-profit international organization Molecular Diversity Preservation International (MDPI).

Mutagenesis is an international multi-disciplinary journal designed to bring together research aimed at the identification, characterization and elucidation of the mechanisms of action of physical, chemical and biological agents capable of producing genetic change in living organisms and the study of the consequences of such changes.

Mutation Research - Genetic Toxicology and Environmental Mutagenesis publishes papers advancing knowledge in the field of genetic toxicology. Papers are welcomed in the following areas:New developments in genotoxicity testing of chemical agents (e.g. improvements in methodology of assay systems and interpretation of results).Alternatives to and refinement of the use of animals in genotoxicity testing.Nano-genotoxicology, the study of genotoxicity hazards and risks related to novel man-made nanomaterials.Studies of epigenetic changes in relation to genotoxic effects.The use of structure-activity relationships in predicting genotoxic effects.The isolation and chemical characterization of novel environmental mutagens.The measurement of genotoxic effects in human populations, when accompanied by quantitative measurements of environmental or occupational exposures.The application of novel technologies for assessing the hazard and risks associated with genotoxic substances (e.g. OMICS or other high-throughput approaches to genotoxicity testing).Mutation Research - Genetic Toxicology and Environmental Mutagenesis is now accepting submissions for a new section of the journal that will be dedicated to the discussion of current issues relating to design, interpretation and strategic use of genotoxicity tests (Current Topics in Genotoxicity Testing). This section is envisaged to include discussions relating to the development of new international testing guidelines, but also to wider topics in the field. The evaluation of contrasting or opposing viewpoints is welcomed as long as the presentation is in accordance with the journal's aims, scope, and policies.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The subject areas of Reviews in Mutation Research encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus this section will cover advances in human genome research (including evolving technologies for mutation detection andfunctional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concern.Genetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section. In addition to full-length reviews, mini-reviews on specific topical themes will be published.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Mycotoxin Research, the official publication of the Society for Mycotoxin Research, is a peer-reviewed, scientific journal dealing with all aspects related to toxic fungal metabolites. The journal publishes original research articles and reviews in all areas dealing with mycotoxins. As an interdisciplinary platform, Mycotoxin Research welcomes submission of scientific contributions in the following research fields:

- Ecology and genetics of mycotoxin formation- Mode of action of mycotoxins, metabolism and toxicology- Agricultural production and mycotoxins- Human and animal health aspects, including exposure studies and risk assessment - Food and feed safety, including occurrence, prevention, regulatory aspects, and control of mycotoxins- Environmental safety and technology-related aspects of mycotoxins- Chemistry, synthesis and analysis

Nano Today is the international journal for researchers with interests across the whole of nanoscience and technology. Through its unique mixture of peer-reviewed articles, the latest research news, and information on key developments, Nano Today provides comprehensive coverage of this exciting and dynamic new field.Description:Nano Today publishes original articles on all aspects of nanoscience and nanotechnology. Manuscripts of three types are considered: Review Articles that inform readers of the latest research and advances in nanoscience and nanotechnology, Rapid Communications that feature exciting research breakthroughs in the field, and News and Opinions that comment on topical issues or express views on the developments in related fields.Contributions include a variety of topics such as:• Synthesis and Self-Assembly of Nanostructured Materials and Films• Functionalization and Size-Dependent Properties of Nanocrystals, Quantum Dots and Nanowires• Processing and Templating of Nanotubes and Nanoporous Materials• Tailoring of Polymeric Nanoparticles, Organic-Inorganic Nanocomposites and Biohybrids• Fabrication of Nano and Micro Electro Mechanical Systems• Design and Engineering of Structural and Functional Nanomaterials• Nanosystems for Biological, Medical, Chemical, Catalytic, Energy and Environmental Applications• Nanodevices for Electronic, Photonic, Magnetic, Imaging, Diagnostic and Sensor Applications

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases. In addition to bimonthly issues, the journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories. The journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.